Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB-WT) Equity Average (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Equity Average for 3 consecutive years, with $315.8 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 34.65% to $315.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $315.8 million through Dec 2025, down 34.65% year-over-year, with the annual reading at $384.8 million for FY2025, 28.01% down from the prior year.
  • Equity Average for Q4 2025 was $315.8 million at Nuvation Bio, down from $349.4 million in the prior quarter.
  • The five-year high for Equity Average was $632.9 million in Q2 2023, with the low at $315.8 million in Q4 2025.
  • Average Equity Average over 3 years is $477.3 million, with a median of $441.6 million recorded in 2025.
  • The sharpest move saw Equity Average crashed 38.53% in 2024, then decreased 6.92% in 2025.
  • Over 3 years, Equity Average stood at $608.4 million in 2023, then decreased by 20.56% to $483.3 million in 2024, then tumbled by 34.65% to $315.8 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $315.8 million, $349.4 million, and $396.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.